The Conundrum of Anticoagulation and Antiplatelet Therapy in Spontaneous Coronary Artery Dissection
Spontaneous coronary artery dissection (SCAD) is a relatively rare and frequently misdiagnosed disease. The current knowledge of its pathophysiology and management is limited and based mostly on hypotheses. We present a patient with recurrent SCAD whose condition worsened soon after discontinuation...
Main Authors: | Andres Cordova Sanchez MC, Emad Mogadam MD, Dana Aiello MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-05-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/23247096221097541 |
Similar Items
-
Oral Anticoagulant and Antiplatelet
Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials
by: Sheng-Lin Ye MD, et al.
Published: (2021-11-01) -
Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
by: Giulia Magnani, et al.
Published: (2023-08-01) -
Spontaneous Coronary Artery Dissection With Concomitant Coronary Vasospasm
by: Kazutoshi Hirose, MD, et al.
Published: (2024-04-01) -
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
by: Verheugt Freek WA, et al.
Published: (2001-05-01) -
What Is New in Spontaneous Coronary Artery Dissection?
by: Cathevine Yang, MD, et al.
Published: (2024-02-01)